DK105391A - Et rent faktor i produkt og fremgangsmaade til fremstilling heraf - Google Patents

Et rent faktor i produkt og fremgangsmaade til fremstilling heraf Download PDF

Info

Publication number
DK105391A
DK105391A DK105391A DK105391A DK105391A DK 105391 A DK105391 A DK 105391A DK 105391 A DK105391 A DK 105391A DK 105391 A DK105391 A DK 105391A DK 105391 A DK105391 A DK 105391A
Authority
DK
Denmark
Prior art keywords
factor
pct
procedure
manufacturing
product
Prior art date
Application number
DK105391A
Other languages
English (en)
Other versions
DK105391D0 (da
Inventor
Karin Oestergaard Alsoee
Jesper Kihl
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK911053A priority Critical patent/DK105391D0/da
Publication of DK105391A publication Critical patent/DK105391A/da
Publication of DK105391D0 publication Critical patent/DK105391D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK911053A 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf DK105391D0 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK911053A DK105391D0 (da) 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat
PCT/DK1989/000297 WO1990006759A1 (en) 1988-12-20 1989-12-19 A pure factor i protein and a process for producing said protein
DK911053A DK105391D0 (da) 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf

Publications (2)

Publication Number Publication Date
DK105391A true DK105391A (da) 1991-06-03
DK105391D0 DK105391D0 (da) 1991-06-03

Family

ID=8149208

Family Applications (2)

Application Number Title Priority Date Filing Date
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat
DK911053A DK105391D0 (da) 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat

Country Status (11)

Country Link
US (1) US5378811A (da)
EP (1) EP0449897B1 (da)
JP (1) JPH04502324A (da)
AT (1) ATE101521T1 (da)
AU (1) AU4811290A (da)
DE (1) DE68913212T2 (da)
DK (2) DK708488D0 (da)
ES (1) ES2062502T3 (da)
FI (1) FI95440C (da)
NO (1) NO912387L (da)
WO (1) WO1990006759A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
EP1107807B1 (en) * 1998-08-25 2006-10-11 Ash Access Technology, Inc. Use of citrate in a catheter lock solution
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
GB0904427D0 (en) 2009-03-13 2009-04-29 Lachmann Peter Treatment of diseases related to hyperactivity of the complement system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤

Also Published As

Publication number Publication date
WO1990006759A1 (en) 1990-06-28
NO912387D0 (no) 1991-06-19
AU4811290A (en) 1990-07-10
DE68913212D1 (de) 1994-03-24
DE68913212T2 (de) 1994-05-19
NO912387L (no) 1991-06-19
EP0449897A1 (en) 1991-10-09
ES2062502T3 (es) 1994-12-16
ATE101521T1 (de) 1994-03-15
FI95440C (fi) 1996-02-12
FI912879A0 (fi) 1991-06-14
DK105391D0 (da) 1991-06-03
DK708488D0 (da) 1988-12-20
US5378811A (en) 1995-01-03
FI95440B (fi) 1995-10-31
EP0449897B1 (en) 1994-02-16
JPH04502324A (ja) 1992-04-23

Similar Documents

Publication Publication Date Title
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
EP0431129A4 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
TR199900145T2 (xx) Is�ya kararl� antifriz proteini ihtiva eden dondurulmu� g�da �r�n�.
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DK0722344T3 (da) Fremgangsmåde til virusinaktivering i nærvær af en polyether og et middel
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
HU895788D0 (en) Process for producing peptides and medical products containing them
DK573587A (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
DE69132889D1 (de) Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
DK105391D0 (da) Et rent faktor i produkt og fremgangsmaade til fremstilling heraf
NO175875C (no) Stöpt gjenstand av nikkelbasert superlegering, den nikkelbaserte superlegering som sådan, og varmebehandling av gjenstanden
ATE180277T1 (de) Zur behandlung von tumoren und hiv-infektionen nützliches pflanzliches protein
DK0571485T3 (da) 3-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse forbindelser
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE59109261D1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DK0722460T3 (da) Peptidderivater der er terapeutisk aktive i blodkoaguleringskaskaden, fremgangsmåde til fremstilling heraf og farmaceutiske
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
DE3867781D1 (de) Verwendung des desmodiums fuer die behandlung von hepatitis und uebereinstimmendes arzneimittel.